CMMB Competitors & Alternatives
Compare Chemomab Therapeutics Ltd DRC with similar stocks in the same industry
Biotechnology
CMMB
Main Stock$2.27
Tradestie Score
50
Market Cap
$13.70M
Analyst Upside
+560.8%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANRO
Alto Neuroscience Inc.
|
$24.78
|
$110.20M | - | 58 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.69
|
$97.42M | - | 55 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$30.43
|
$76.55M | - | 58 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.28
|
$71.69M | - | 52 | Compare |
|
ABVC
ABVC BioPharma, Inc. Common Stock
|
$1.80
|
$70.39M | - | 60 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.34
|
$67.94M | - | 56 | Compare |
|
EVAX
Evaxion A/S American Depositary Share
|
$3.41
|
$28.05M | - | 55 | Compare |
|
LIXT
Lixte Biotechnology Holdings, Inc. Common Stock
|
$7.21
|
$21.94M | - | 54 | Compare |
|
PALI
Palisade Bio, Inc. Common Stock
|
$2.10
|
$12.21M | 16.4 | 52 | Compare |
|
BBLG
Bone Biologics Corp Common Stock
|
$1.42
|
$5.01M | - | 54 | Compare |
More CMMB Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2834)
237 stocks in this industry